Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents

Cell

Volumn 180, Issue 2, 2020, Pages 221-232

  Walter, Jens ^a,b,c   Armet, Anissa M ^a   Finlay, B Brett ^d,e   Shanahan, Fergus ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

causality; chronic disease; dysbiosis; fecal transplant; germ free; gnotobiotic; human; humanized; microbiome; microbiota; murine models; rodents

Indexed keywords

EXPERIMENTAL DESIGN; HUMAN; HUMAN MICROBIOTA ASSOCIATED RODENT; INTESTINE FLORA; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; ANIMAL; ANIMAL MODEL; DISEASES; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; MICROBIOLOGY; MICROFLORA; MOUSE; PHYSIOLOGY; PROCEDURES; RAT;

ANIMALS; DISEASE; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; MICE; MICROBIOTA; MODELS, ANIMAL; RATS; RODENTIA;

EID: 85078055281     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2019.12.025     Document Type: Review

References (115)

1. Arrieta, M.C., Stiemsma, L.T., Dimitriu, P.A., Thorson, L., Russell, S., Yurist-Doutsch, S., Kuzeljevic, B., Gold, M.J., Britton, H.M., Lefebvre, D.L., et al., CHILD Study Investigators. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med., 7, 2015, 307ra152.
2. Arrieta, M.C., Walter, J., Finlay, B.B., Human microbiota-associated mice: a model with challenges. Cell Host Microbe 19 (2016), 575–578.
3. Atkinson, M.A., Chervonsky, A., Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55 (2012), 2868–2877.
4. Battaglioli, E.J., Hale, V.L., Chen, J., Jeraldo, P., Ruiz-Mojica, C., Schmidt, B.A., Rekdal, V.M., Till, L.M., Huq, L., Smits, S.A., et al. Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea. Sci. Transl. Med., 10, 2018, eaam7019.
5. Baxter, N.T., Zackular, J.P., Chen, G.Y., Schloss, P.D., Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome, 2, 2014, 20.
6. Begley, C.G., Ioannidis, J.P., Reproducibility in science: improving the standard for basic and preclinical research. Circ. Res. 116 (2015), 116–126.
7. Belzung, C., Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?. Neuropsychopharmacology 39 (2014), 1041–1051.
8. Berer, K., Gerdes, L.A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S.E., et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc. Natl. Acad. Sci. USA 114 (2017), 10719–10724.
9. Bourrat, P., Have causal claims about the gut microbiome been over-hyped?. BioEssays, 40, 2018, e1800178.
10. Bowers, R.M., Kyrpides, N.C., Stepanauskas, R., Harmon-Smith, M., Doud, D., Reddy, T.B.K., Schulz, F., Jarett, J., Rivers, A.R., Eloe-Fadrosh, E.A., et al., Genome Standards Consortium. Minimum information about a single amplified genome (MISAG) and a metagenome-assembled genome (MIMAG) of bacteria and archaea. Nat. Biotechnol. 35 (2017), 725–731.
11. Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C.A., Causton, H.C., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29 (2001), 365–371.
12. Britton, G.J., Contijoch, E.J., Mogno, I., Vennaro, O.H., Llewellyn, S.R., Ng, R., Li, Z., Mortha, A., Merad, M., Das, A., et al. Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORγt+ regulatory T cells and exacerbate colitis in mice. Immunity 50 (2019), 212–224.e4.
13. Brüssow, H., Problems with the concept of gut microbiota dysbiosis. Microb. Biotechnol. 0 (2019), 1–12.
14. Byrd, A.L., Segre, J.A., Infectious disease. Adapting Koch's postulates. Science 351 (2016), 224–226.
15. Cani, P.D., Severe obesity and gut microbiota: does bariatric surgery really reset the system?. Gut 68 (2019), 5–6.
16. Cekanaviciute, E., Yoo, B.B., Runia, T.F., Debelius, J.W., Singh, S., Nelson, C.A., Kanner, R., Bencosme, Y., Lee, Y.K., Hauser, S.L., et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc. Natl. Acad. Sci. USA 114 (2017), 10713–10718.
17. Chen, Y.-J., Wu, H., Wu, S.-D., Lu, N., Wang, Y.-T., Liu, H.-N., Dong, L., Liu, T.-T., Shen, X.-Z., Parasutterella, in association with irritable bowel syndrome and intestinal chronic inflammation. J. Gastroenterol. Hepatol. 33 (2018), 1844–1852.
18. Chiu, C.-C., Ching, Y.-H., Li, Y.-P., Liu, J.-Y., Huang, Y.-T., Huang, Y.-W., Yang, S.-S., Huang, W.-C., Chuang, H.-L., Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic steatohepatitis. Nutrients, 9, 2017, 1220.
19. Chung, H., Pamp, S.J., Hill, J.A., Surana, N.K., Edelman, S.M., Troy, E.B., Reading, N.C., Villablanca, E.J., Wang, S., Mora, J.R., et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149 (2012), 1578–1593.
20. Collins, J.W., Keeney, K.M., Crepin, V.F., Rathinam, V.A., Fitzgerald, K.A., Finlay, B.B., Frankel, G., Citrobacter rodentium: infection, inflammation and the microbiota. Nat. Rev. Microbiol. 12 (2014), 612–623.
21. Coombes, B.K., Coburn, B.A., Potter, A.A., Gomis, S., Mirakhur, K., Li, Y., Finlay, B.B., Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect. Immun. 73 (2005), 7161–7169.
22. de Groot, P.F., Frissen, M.N., de Clercq, N.C., Nieuwdorp, M., Fecal microbiota transplantation in metabolic syndrome: history, present and future. Gut Microbes 8 (2017), 253–267.
23. De Palma, G., Lynch, M.D., Lu, J., Dang, V.T., Deng, Y., Jury, J., Umeh, G., Miranda, P.M., Pigrau Pastor, M., Sidani, S., et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci. Transl. Med., 9, 2017, eaaf6397.
24. Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N.M., et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25 (2019), 1096–1103.
25. Dhakal, S., Wang, L., Antony, L., Rank, J., Bernardo, P., Ghimire, S., Bondra, K., Siems, C., Lakshmanappa, Y.S., Renu, S., et al. Amish (rural) vs. non-Amish (urban) infant fecal microbiotas are highly diverse and their transplantation lead to differences in mucosal immune maturation in a humanized germfree piglet model. Front. Immunol., 10, 2019, 1509.
26. Douglas, A.E., Which experimental systems should we use for human microbiome science?. PLoS Biol., 16, 2018, e2005245.
27. Duvallet, C., Gibbons, S.M., Gurry, T., Irizarry, R.A., Alm, E.J., Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat. Commun., 8, 2017, 1784.
28. Editorial, Rewarding negative results keeps science on track. Nature, 551, 2017, 414.
29. Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M.J., Valles-Colomer, M., Vandeputte, D., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
30. Fanelli, D., Negative results are disappearing from most disciplines and countries. Scientometrics 90 (2012), 891–904.
31. Feehley, T., Plunkett, C.H., Bao, R., Choi Hong, S.M., Culleen, E., Belda-Ferre, P., Campbell, E., Aitoro, R., Nocerino, R., Paparo, L., et al. Healthy infants harbor intestinal bacteria that protect against food allergy. Nat. Med. 25 (2019), 448–453.
32. Fielding, R.A., Reeves, A.R., Jasuja, R., Liu, C., Barrett, B.B., Lustgarten, M.S., Muscle strength is increased in mice that are colonized with microbiota from high-functioning older adults. Exp. Gerontol., 127, 2019, 110722.
33. Fischbach, M.A., Microbiome: focus on causation and mechanism. Cell 174 (2018), 785–790.
34. Franklin, C.L., Ericsson, A.C., Microbiota and reproducibility of rodent models. Lab Anim. (NY) 46 (2017), 114–122.
35. Freudenberg, F., O'Leary, A., Aguiar, D.C., Slattery, D.A., Challenges with modelling anxiety disorders: a possible hindrance for drug discovery. Expert Opin. Drug Discov. 13 (2018), 279–281.
36. Fujii, Y., Nguyen, T.T.T., Fujimura, Y., Kameya, N., Nakamura, S., Arakawa, K., Morita, H., Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer's disease. Biosci. Biotechnol. Biochem. 83 (2019), 2144–2152.
37. Garcia, S., Freitas, A.A., Humanized mice: current states and perspectives. Immunol. Lett. 146 (2012), 1–7.
38. Ge, X., Zhao, W., Ding, C., Tian, H., Xu, L., Wang, H., Ni, L., Jiang, J., Gong, J., Zhu, W., et al. Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility. Sci. Rep., 7, 2017, 441.
39. Gelfand, L.A., Mensinger, J.L., Tenhave, T., Mediation analysis: a retrospective snapshot of practice and more recent directions. J. Gen. Psychol. 136 (2009), 153–176.
40. Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J.T., et al. Human genetics shape the gut microbiome. Cell 159 (2014), 789–799.
41. Gupta, S., Allen-Vercoe, E., Petrof, E.O., Fecal microbiota transplantation: in perspective. Therap. Adv. Gastroenterol. 9 (2016), 229–239.
42. Hanage, W.P., Microbiology: microbiome science needs a healthy dose of scepticism. Nature 512 (2014), 247–248.
43. Heinritz, S.N., Mosenthin, R., Weiss, E., Use of pigs as a potential model for research into dietary modulation of the human gut microbiota. Nutr. Res. Rev. 26 (2013), 191–209.
44. Henderson, C.J., Kapelyukh, Y., Scheer, N., Rode, A., McLaren, A.W., MacLeod, A.K., Lin, D., Wright, J., Stanley, L.A., Wolf, C.R., An extensively humanized mouse model to predict pathways of drug disposition and drug/drug interactions, and to facilitate design of clinical trials. Drug Metab. Dispos. 47 (2019), 601–615.
45. Hill, S.M., Heiser, L.M., Cokelaer, T., Unger, M., Nesser, N.K., Carlin, D.E., Zhang, Y., Sokolov, A., Paull, E.O., Wong, C.K., et al., HPN-DREAM Consortium. Inferring causal molecular networks: empirical assessment through a community-based effort. Nat. Methods 13 (2016), 310–318.
46. Hooks, K.B., O'Malley, M.A., Dysbiosis and its discontents. MBio, 8, 2017 e01492-17.
47. Huttenhower, C., Kostic, A.D., Xavier, R.J., Inflammatory bowel disease as a model for translating the microbiome. Immunity 40 (2014), 843–854.
48. Janssens, Y., Nielandt, J., Bronselaer, A., Debunne, N., Verbeke, F., Wynendaele, E., Van Immerseel, F., Vandewynckel, Y.P., De Tré, G., De Spiegeleer, B., Disbiome database: linking the microbiome to disease. BMC Microbiol., 18, 2018, 50.
49. Kau, A.L., Planer, J.D., Liu, J., Rao, S., Yatsunenko, T., Trehan, I., Manary, M.J., Liu, T.C., Stappenbeck, T.S., Maleta, K.M., et al. Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy. Sci. Transl. Med., 7, 2015, 276ra24.
50. Kazdoba, T.M., Leach, P.T., Yang, M., Silverman, J.L., Solomon, M., Crawley, J.N., Translational mouse models of autism: advancing toward pharmacological therapeutics. Curr. Top. Behav. Neurosci. 28 (2016), 1–52.
51. Kelly, J.R., Borre, Y., O’ Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P.J., Beers, S., Scott, K., Moloney, G., et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J. Psychiatr. Res. 82 (2016), 109–118.
52. Koren, O., Goodrich, J.K., Cullender, T.C., Spor, A., Laitinen, K., Bäckhed, H.K., Gonzalez, A., Werner, J.J., Angenent, L.T., Knight, R., et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150 (2012), 470–480.
53. Koskella, B., Hall, L.J., Metcalf, C.J.E., The microbiome beyond the horizon of ecological and evolutionary theory. Nat. Ecol. Evol. 1 (2017), 1606–1615.
54. Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y.S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Björck, I., Bäckhed, F., Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab. 22 (2015), 971–982.
55. Lazic, S.E., Clarke-Williams, C.J., Munafò, M.R., What exactly is ‘N’ in cell culture and animal experiments?. PLoS Biol., 16, 2018, e2005282.
56. Leong, C., Haszard, J.J., Lawley, B., Otal, A., Taylor, R.W., Szymlek-Gay, E.A., Fleming, E.A., Daniels, L., Fangupo, L.J., Tannock, G.W., Heath, A.M., Mediation analysis as a means of identifying dietary components that differentially affect the fecal microbiota of infants weaned by modified baby-led and traditional approaches. Appl. Environ. Microbiol. 84 (2018), e00914–e00918.
57. Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., Wu, S., Liu, W., Cui, Q., Geng, B., et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome, 5, 2017, 14.
58. Li, S.X., Sen, S., Schneider, J.M., Xiong, K.N., Nusbacher, N.M., Moreno-Huizar, N., Shaffer, M., Armstrong, A.J.S., Severs, E., Kuhn, K., et al. Gut microbiota from high-risk men who have sex with men drive immune activation in gnotobiotic mice and in vitro HIV infection. PLoS Pathog., 15, 2019, e1007611.
59. Liu, R., Hong, J., Xu, X., Feng, Q., Zhang, D., Gu, Y., Shi, J., Zhao, S., Liu, W., Wang, X., et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat. Med. 23 (2017), 859–868.
60. Liu, R., Kang, J.D., Sartor, R.B., Sikaroodi, M., Fagan, A., Gavis, E.A., Zhou, H., Hylemon, P.B., Herzog, J.W., Li, X., et al. Neuroinflammation in murine cirrhosis is dependent on the gut microbiome and is attenuated by fecal transplant. Hepatology, 2019, 10.1002/hep.30827 Published online June 20, 2019.
61. Lloyd-Price, J., Arze, C., Ananthakrishnan, A.N., Schirmer, M., Avila-Pacheco, J., Poon, T.W., Andrews, E., Ajami, N.J., Bonham, K.S., Brislawn, C.J., et al., IBDMDB Investigators. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569 (2019), 655–662.
62. Lynch, K.E., Parke, E.C., O'Malley, M.A., How causal are microbiomes? A comparison with the Helicobacter pylori explanation of ulcers. Biol. Philos., 34, 2019, 62.
63. Maeda, Y., Kurakawa, T., Umemoto, E., Motooka, D., Ito, Y., Gotoh, K., Hirota, K., Matsushita, M., Furuta, Y., Narazaki, M., et al. Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine. Arthritis Rheumatol. 68 (2016), 2646–2661.
64. Marcobal, A., Kashyap, P.C., Nelson, T.A., Aronov, P.A., Donia, M.S., Spormann, A., Fischbach, M.A., Sonnenburg, J.L., A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J. 7 (2013), 1933–1943.
65. Martínez, I., Maldonado-Gómez, M.X., Gomes-Neto, J.C., Kittana, H., Ding, H., Schmaltz, R., Joglekar, P., Cardona, R.J., Marsteller, N.L., Kembel, S.W., et al. Experimental evaluation of the importance of colonization history in early-life gut microbiota assembly. eLife, 7, 2018, e36521.
66. Maruvada, P., Leone, V., Kaplan, L.M., Chang, E.B., The human microbiome and obesity: moving beyond associations. Cell Host Microbe 22 (2017), 589–599.
67. Matosin, N., Frank, E., Engel, M., Lum, J.S., Newell, K.A., Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture. Dis. Model. Mech. 7 (2014), 171–173.
68. McBurney, M.I., Davis, C., Fraser, C.M., Schneeman, B.O., Huttenhower, C., Verbeke, K., Walter, J., Latulippe, M.E., Establishing what constitutes a healthy human gut microbiome: state of the science, regulatory considerations, and future directions. J. Nutr. 149 (2019), 1882–1895.
69. Nagao-Kitamoto, H., Shreiner, A.B., Gillilland, M.G. 3rd, Kitamoto, S., Ishii, C., Hirayama, A., Kuffa, P., El-Zaatari, M., Grasberger, H., Seekatz, A.M., et al. Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice. Cell. Mol. Gastroenterol. Hepatol. 2 (2016), 468–481.
70. Namasivayam, S., Kauffman, K.D., McCulloch, J.A., Yuan, W., Thovarai, V., Mittereder, L.R., Trinchieri, G., Barber, D.L., Sher, A., Correlation between disease severity and the intestinal microbiome in Mycobacterium tuberculosis-infected rhesus macaques. MBio 10 (2019), e01018–e01019.
71. Natividad, J.M., Pinto-Sanchez, M.I., Galipeau, H.J., Jury, J., Jordana, M., Reinisch, W., Collins, S.M., Bercik, P., Surette, M.G., Allen-Vercoe, E., Verdu, E.F., Ecobiotherapy rich in Firmicutes decreases susceptibility to colitis in a humanized gnotobiotic mouse model. Inflamm. Bowel Dis. 21 (2015), 1883–1893.
72. Neville, B.A., Forster, S.C., Lawley, T.D., Commensal Koch's postulates: establishing causation in human microbiota research. Curr. Opin. Microbiol. 42 (2018), 47–52.
73. Ni, J., Wu, G.D., Albenberg, L., Tomov, V.T., Gut microbiota and IBD: causation or correlation?. Nat. Rev. Gastroenterol. Hepatol. 14 (2017), 573–584.
74. Nishida, A.H., Ochman, H., A great-ape view of the gut microbiome. Nat. Rev. Genet. 20 (2019), 195–206.
75. Nissen, S.B., Magidson, T., Gross, K., Bergstrom, C.T., Publication bias and the canonization of false facts. eLife, 5, 2016, e21451.
76. Olle, B., Medicines from microbiota. Nat. Biotechnol. 31 (2013), 309–315.
77. Parsonnet, J., Friedman, G.D., Vandersteen, D.P., Chang, Y., Vogelman, J.H., Orentreich, N., Sibley, R.K., Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325 (1991), 1127–1131.
78. Petursdottir, D.H., Nordlander, S., Qazi, K.R., Carvalho-Queiroz, C., Ahmed Osman, O., Hell, E., Björkander, S., Haileselassie, Y., Navis, M., Kokkinou, E., et al. Early-life human microbiota associated with childhood allergy promotes the T helper 17 axis in mice. Front. Immunol., 8, 2017, 1699.
79. Poole, A.C., Goodrich, J.K., Youngblut, N.D., Luque, G.G., Ruaud, A., Sutter, J.L., Waters, J.L., Shi, Q., El-Hadidi, M., Johnson, L.M., et al. Human salivary amylase gene copy number impacts oral and gut microbiomes. Cell Host Microbe 25 (2019), 553–564.e7.
80. Popper, K., Science as falsification. Conjectures and Refutations, 1963, Routledge, 30–39.
81. Quach, D., Collins, F., Parameswaran, N., McCabe, L., Britton, R.A., Microbiota reconstitution does not cause bone loss in germ-free mice. MSphere, 3, 2018 e00545-17.
82. Reigstad, C.S., Salmonson, C.E., Rainey, J.F. 3rd, Szurszewski, J.H., Linden, D.R., Sonnenburg, J.L., Farrugia, G., Kashyap, P.C., Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 29 (2015), 1395–1403.
83. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
84. Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P.I., Godneva, A., Kalka, I.N., Bar, N., et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555 (2018), 210–215.
85. Round, J.L., Palm, N.W., Causal effects of the microbiota on immune-mediated diseases. Sci. Immunol., 3, 2018, eaao1603.
86. Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Schretter, C.E., Rocha, S., Gradinaru, V., et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167 (2016), 1469–1480.e12.
87. Sanna, S., van Zuydam, N.R., Mahajan, A., Kurilshikov, A., Vich Vila, A., Võsa, U., Mujagic, Z., Masclee, A.A.M., Jonkers, D.M.A.E., Oosting, M., et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat. Genet. 51 (2019), 600–605.
88. Sawasvirojwong, S., Srimanote, P., Chatsudthipong, V., Muanprasat, C., An adult mouse model of Vibrio cholerae-induced diarrhea for studying pathogenesis and potential therapy of cholera. PLoS Negl. Trop. Dis., 7, 2013, e2293.
89. Scargle, J., Publication bias: the “file-drawer” problem in scientific inference. J. Sci. Explor. 14 (2000), 91–106.
90. Schmidt, T.S.B., Raes, J., Bork, P., The human gut microbiome: from association to modulation. Cell 172 (2018), 1198–1215.
91. Shanahan, F., Separating the microbiome from the hyperbolome. Genome Med., 7, 2015, 17.
92. Shanahan, F., Hill, C., Language, numeracy and logic in microbiome science. Nat. Rev. Gastroenterol. Hepatol. 16 (2019), 387–388.
93. Sharon, G., Cruz, N.J., Kang, D.W., Gandal, M.J., Wang, B., Kim, Y.M., Zink, E.M., Casey, C.P., Taylor, B.C., Lane, C.J., et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell 177 (2019), 1600–1618.e17.
94. Smith, M.I., Yatsunenko, T., Manary, M.J., Trehan, I., Mkakosya, R., Cheng, J., Kau, A.L., Rich, S.S., Concannon, P., Mychaleckyj, J.C., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339 (2013), 548–554.
95. Soderborg, T.K., Clark, S.E., Mulligan, C.E., Janssen, R.C., Babcock, L., Ir, D., Young, B., Krebs, N., Lemas, D.J., Johnson, L.K., et al. The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nat. Commun., 9, 2018, 4462.
96. Sohn, M.B., Li, H., Compositional mediation analysis for microbiome studies. Ann. Appl. Stat. 13 (2019), 661–681.
97. Staley, C., Kaiser, T., Beura, L.K., Hamilton, M.J., Weingarden, A.R., Bobr, A., Kang, J., Masopust, D., Sadowsky, M.J., Khoruts, A., Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning. Microbiome, 5, 2017, 87.
98. Steimer, T., Animal models of anxiety disorders in rats and mice: some conceptual issues. Dialogues Clin. Neurosci. 13 (2011), 495–506.
99. Stoll, M.L., Pierce, M.K., Watkins, J.A., Zhang, M., Weiss, P.F., Weiss, J.E., Elson, C.O., Cron, R.Q., Kumar, R., Morrow, C.D., Schoeb, T.R., Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis. Genes Immun. 20 (2019), 158–166.
100. Tomkovich, S., Dejea, C.M., Winglee, K., Drewes, J.L., Chung, L., Housseau, F., Pope, J.L., Gauthier, J., Sun, X., Mühlbauer, M., et al. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic. J. Clin. Invest. 130 (2019), 1699–1712.
101. Torres, J., Hu, J., Seki, A., Eisele, C., Nair, N., Huang, R., Tarassishin, L., Jharap, B., Cote-Daigneault, J., Mao, Q., et al. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. Gut 69 (2020), 42–51.
102. Touw, K., Ringus, D.L., Hubert, N., Wang, Y., Leone, V.A., Nadimpalli, A., Theriault, B.R., Huang, Y.E., Tune, J.D., Herring, P.B., et al. Mutual reinforcement of pathophysiological host-microbe interactions in intestinal stasis models. Physiol. Rep., 5, 2017, e13182.
103. Turnbaugh, P.J., Ridaura, V.K., Faith, J.J., Rey, F.E., Knight, R., Gordon, J.I., The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med., 1, 2009, 6ra14.
104. Vandeputte, D., Tito, R.Y., Vanleeuwen, R., Falony, G., Raes, J., Practical considerations for large-scale gut microbiome studies. FEMS Microbiol. Rev. 41:Supp_1 (2017), S154–S167.
105. Wagner, V.E., Dey, N., Guruge, J., Hsiao, A., Ahern, P.P., Semenkovich, N.P., Blanton, L.V., Cheng, J., Griffin, N., Stappenbeck, T.S., et al. Effects of a gut pathobiont in a gnotobiotic mouse model of childhood undernutrition. Sci. Transl. Med., 8, 2016, 366ra164.
106. Walsh, N.C., Kenney, L.L., Jangalwe, S., Aryee, K.E., Greiner, D.L., Brehm, M.A., Shultz, L.D., Humanized mouse models of clinical disease. Annu. Rev. Pathol. 12 (2017), 187–215.
107. Walter, J., Maldonado-Gómez, M.X., Martínez, I., To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes. Curr. Opin. Biotechnol. 49 (2018), 129–139.
108. Wang, J., Thingholm, L.B., Skiecevičienė, J., Rausch, P., Kummen, M., Hov, J.R., Degenhardt, F., Heinsen, F.A., Rühlemann, M.C., Szymczak, S., et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat. Genet. 48 (2016), 1396–1406.
109. Wong, S.H., Zhao, L., Zhang, X., Nakatsu, G., Han, J., Xu, W., Xiao, X., Kwong, T.N.Y., Tsoi, H., Wu, W.K.K., et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology 153 (2017), 1621–1633.e6.
110. Woodward, J., Causation in biology: stability, specificity, and the choice of levels of explanation. Biol. Philos. 25 (2010), 287–318.
111. Woodward, J., Causation and manipulability. Zalta, E.N., (eds.) The Stanford Encyclopedia of Philosophy, 2016, Stanford University.
112. Yassour, M., Lim, M.Y., Yun, H.S., Tickle, T.L., Sung, J., Song, Y.M., Lee, K., Franzosa, E.A., Morgan, X.C., Gevers, D., et al. Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med., 8, 2016, 17.
113. Zhang, L., Bahl, M.I., Roager, H.M., Fonvig, C.E., Hellgren, L.I., Frandsen, H.L., Pedersen, O., Holm, J.C., Hansen, T., Licht, T.R., Environmental spread of microbes impacts the development of metabolic phenotypes in mice transplanted with microbial communities from humans. ISME J. 11 (2017), 676–690.
114. Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol. Psychiatry 21 (2016), 786–796.
115. Zheng, P., Zeng, B., Liu, M., Chen, J., Pan, J., Han, Y., Liu, Y., Cheng, K., Zhou, C., Wang, H., et al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci. Adv., 5, 2019, eaau8317.